All In Biotech

Drug Trial Radar · NCT01215253

Ranolazine Implantable Cardioverter-Defibrillator Trial

Late Sodium Current Blockade in High-Risk ICD Patients

Last checked: Nov 20, 2026Latest source record: Aug 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,012 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,012

Actual

Start

Sep 2011

Primary completion

Feb 28, 2017

Study completion Feb 28, 2017

Sponsor

Lead sponsor
University of RochesterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 6, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to see how effective a drug called ranolazine is in reducing the risk of ventricular arrhythmia and death in people with implantable cardioverter-defibrillators (ICDs). This drug will be used with standard medications that is routinely prescribed in enrolled patients.

Conditions

  • Ischemic Cardiomyopathy
  • Nonischemic Cardiomyopathy
  • Heart Failure

Interventions

  • RanolazineDrug

    At enrollment, patients will be randomized to ranolazine or placebo. In the active drug arm each patient will be started on a 500 mg twice a day dose for one week with subsequent increase to 1000 mg twice a day at beginning of second week.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Patients With Ventricular Tachycardia (VT) or Ventricular Fibrillation (VF) or DeathTime frame: 2 years of follow-up on average

Locations

90 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Arizona

    Tucson, Arizona

  • Arkansas Cardiology

    Little Rock, Arkansas

  • Sequoia Hospital

    East Palo Alto, California

  • Good Samaritan Hospital

    Los Angeles, California

  • Huntington Memorial Hospital

    Pasadena, California

  • Regional Cardiology Associates

    Sacramento, California

  • Delta Heart and Medical Clinic

    Stockton, California

  • University of Colorado Health - MHS

    Colorado Springs, Colorado

  • Bridgeport Hospital

    Bridgeport, Connecticut

  • Hartford Hospital

    Hartford, Connecticut

  • Washington Electrophysiology/Cardiovascular Research Institute

    Washington D.C., District of Columbia

  • Bay Area Cardiology Associates, P.A.

    Brandon, Florida

  • University of Florida/Cardiovascular Medicine

    Gainesville, Florida

  • University of Florida Health Science Center at Jacksonville

    Jacksonville, Florida

  • Watson Clincia Center for Research Inc.

    Lakeland, Florida

  • Florida Hospital

    Orlando, Florida

  • Tallahassee Research Institute, Inc.

    Tallahassee, Florida

  • Georgia Health Sciences University

    Augusta, Georgia

  • Georgia Arrhythmia Consultants

    Macon, Georgia

  • University of Chicago Hospital

    Chicago, Illinois

  • Peakview Research Center

    Fort Wayne, Indiana

  • LaPorte Hospital

    Hobart, Indiana

  • University of Iowa

    Iowa City, Iowa

  • Central Baptist Hospital

    Lexington, Kentucky

  • Louisiana State University Health Sciences Center- New Orleans

    New Orleans, Louisiana

  • University of Maryland Medical Center

    Baltimore, Maryland

  • Johns Hopkins University

    Baltimore, Maryland

  • MedStar Southern Maryland Hospital Center

    Clinton, Maryland

  • Tufts-New England Medical Center

    Boston, Massachusetts

  • Lahey Clinic

    Burlington, Massachusetts

  • University of Massachusetts-Worchester

    Worcester, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • William Beaumont Hospital - Royal Oak

    Royal Oak, Michigan

  • Michigan Heart

    Ypsilanti, Michigan

  • St. Luke's Hospital Association of Duluth

    Duluth, Minnesota

  • University of Minnesota

    Minneapolis, Minnesota

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • University of Missouri

    Columbia, Missouri

  • Kansas City Heart Foundation

    Kansas City, Missouri

  • Cooper University Hospital

    Camden, New Jersey

Showing 40 of 90 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.